Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Occlusion rate, venous symptoms and patient satisfaction after radiofrequency-induced thermotherapy (RFITT®): are there differences between the great and the small saphenous veins?

Doerler M, Blenkers T, Reich-Schupke S, Altmeyer P, Stücker M.

Vasa. 2015 May;44(3):203-10. doi: 10.1024/0301-1526/a000431.

PMID:
26098324
2.

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.

Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group.

PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015 Mar.

3.

A novel epidermal growth factor--containing wound dressing for the treatment of hard-to-heal venous leg ulcers.

Doerler M, Eming S, Dissemond J, Wolter A, Stoffels-Weindorf M, Reich-Schupke S, Altmeyer P, Stücker M.

Adv Skin Wound Care. 2014 Oct;27(10):456-60. doi: 10.1097/01.ASW.0000451942.39446.c2.

PMID:
25225992
4.

Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.

Nordell AD, McKenna M, Borges ÁH, Duprez D, Neuhaus J, Neaton JD; INSIGHT SMART, ESPRIT Study Groups; SILCAAT Scientific Committee.

J Am Heart Assoc. 2014 May 28;3(3):e000844. doi: 10.1161/JAHA.114.000844.

5.

Compression and venous ulcers.

Stücker M, Link K, Reich-Schupke S, Altmeyer P, Doerler M.

Phlebology. 2013 Mar;28 Suppl 1:68-72. doi: 10.1177/0268355512475120. Review.

PMID:
23482538
6.

Foam sclerotherapy with enoxaparin prophylaxis in high-risk patients with postthrombotic syndrome.

Reich-Schupke S, Doerler M, Altmeyer P, Stücker M.

Vasa. 2013 Jan;42(1):50-5. doi: 10.1024/0301-1526/a000247.

PMID:
23385226
7.

Impact on wound healing and efficacy of various leg ulcer debridement techniques.

Doerler M, Reich-Schupke S, Altmeyer P, Stücker M.

J Dtsch Dermatol Ges. 2012 Sep;10(9):624-32. doi: 10.1111/j.1610-0387.2012.07952.x. Epub 2012 May 16. Review. English, German.

8.

Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT).

Pett SL, Carey C, Lin E, Wentworth D, Lazovski J, Miró JM, Gordin F, Angus B, Rodriguez-Barradas M, Rubio R, Tambussi G, Cooper DA, Emery S; INSIGHT-ESPRIT Study Group.

HIV Med. 2011 Apr;12(4):219-27. doi: 10.1111/j.1468-1293.2010.00875.x. Epub 2010 Aug 31.

9.

Interleukin-2 therapy in patients with HIV infection.

INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee, Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G, Wentworth D.

N Engl J Med. 2009 Oct 15;361(16):1548-59. doi: 10.1056/NEJMoa0903175.

10.

Does chemosensitivity-assay-directed therapy have an influence on the prognosis of patients with malignant melanoma stage IV? A retrospective study of 14 patients with malignant melanoma stage IV.

Doerler M, Hyun J, Venten I, Potthoff A, Bartke U, Serova K, Hoextermann S, Altmeyer P, Brockmeyer NH.

Eur J Med Res. 2007 Oct 30;12(10):497-502.

PMID:
18024256
11.

Subtype and genotypic resistance analysis of HIV-1 infected patients in Austria.

Falkensammer B, Doerler M, Kessler HH, Puchhammer-Stoeckl E, Parson W, Duftner C, Dierich MP, Stoiber H.

Wien Klin Wochenschr. 2007;119(5-6):181-5.

PMID:
17427022
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk